We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$946M
AUM Growth
+$84.3M
(+9.8%)
Cap. Flow
+$58.4M
Cap. Flow
% of AUM
6.17%
Top 10 Holdings %
Top 10 Hldgs %
5.74%
Holding
1,852
New
717
Increased
240
Reduced
255
Closed
635
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$5.94M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.81M |
| 3 |
Xcel Energy
XEL
|
+$5.01M |
| 4 |
General Mills
GIS
|
+$4.97M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.75M |
| 2 |
United Parcel Service
UPS
|
+$4.82M |
| 3 |
Yum! Brands
YUM
|
+$4.38M |
| 4 |
ConocoPhillips
COP
|
+$3.98M |
| 5 |
DuPont de Nemours
DD
|
+$3.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.69% |
| 2 | Consumer Discretionary | 14.91% |
| 3 | Industrials | 14.15% |
| 4 | Technology | 11.51% |
| 5 | Healthcare | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Caribou Biosciences
CRBU
$148M
| $188K | 0.02% |
+44,155
| New | +$198K |
|
952
Patterson-UTI
PTEN
$3.48B
| $187K | 0.02% |
15,616
-40,524
| -72% | -$457K |
|
953
Amplify Energy
AMPY
$152M
| $186K | 0.02% |
+27,444
| New | +$191K |
|
954
NerdWallet
NRDS
$630M
| $185K | 0.02% |
+19,676
| New | +$222K |
|
955
Nektar Therapeutics
NKTR
$2.39B
| $179K | 0.02% |
+20,800
| New | +$222K |
|
956
Pebblebrook Hotel Trust
PEB
$2.2B
| $179K | 0.02% |
12,848
-15,203
| -54% | -$212K |
|
957
Provident Financial Services
PFS
$3.15B
| $178K | 0.02% |
+10,918
| New | +$186K |
|
|
HOUS
958
DELISTED
Anywhere Real Estate
HOUS
| $177K | 0.02% |
26,447
-10,974
| -29% | -$65.8K |
|
|
ONTF
959
DELISTED
ON24
ONTF
| $176K | 0.02% |
+21,666
| New | +$180K |
|
|
TE
960
T1 Energy
TE
$1.16B
| $176K | 0.02% |
18,801
-1,887
| -9% | -$14.2K |
|
|
TPC
961
Tutor Perini Cor
TPC
$4.31B
| $175K | 0.02% |
+24,410
| New | +$146K |
|
962
Ecopetrol
EC
$32.5B
| $174K | 0.02% |
16,973
-26,918
| -61% | -$272K |
|
|
VRN
963
DELISTED
Veren
VRN
| $174K | 0.02% |
25,844
+5,860
| +29% | +$40.8K |
|
964
Alto Ingredients
ALTO
$345M
| $172K | 0.02% |
59,558
+40,748
| +217% | +$77.6K |
|
965
Blue Owl Capital
OBDC
$5.47B
| $171K | 0.02% |
+12,765
| New | +$167K |
|
966
Lumen
LUMN
$6.38B
| $171K | 0.02% |
+75,650
| New | +$167K |
|
967
Kosmos Energy
KOS
$1.39B
| $170K | 0.02% |
+28,457
| New | +$185K |
|
968
Bally's
BALY
$720M
| $169K | 0.02% |
+10,875
| New | +$175K |
|
969
a.k.a. Brands
AKA
$119M
| $169K | 0.02% |
+32,687
| New | +$160K |
|
|
BRKL
970
DELISTED
Brookline Bancorp
BRKL
| $168K | 0.02% |
+19,236
| New | +$175K |
|
971
Celestica
CLS
$40.3B
| $168K | 0.02% |
11,578
-6,819
| -37% | -$84.4K |
|
972
Resources Connection
RGP
$136M
| $165K | 0.02% |
+10,520
| New | +$164K |
|
973
Atara Biotherapeutics
ATRA
$70.4M
| $160K | 0.02% |
+3,987
| New | +$225K |
|
974
Rocket Companies
RKT
$39.6B
| $160K | 0.02% |
+17,851
| New | +$155K |
|
975
Focus Universal
FCUV
$1.48M
| $160K | 0.02% |
+261
| New | +$183K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2023 Portfolio in Review
As of Q2 2023, Y-Intercept (HK) held 1,852 positions worth $946M, up 9.8% from $861M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Y-Intercept (HK) deployed $58.4M of net new capital in Q2 2023, opening 717 new positions and adding to 240 existing holdings. Its largest new stake was Union Pacific: 29,892 shares worth $6.12M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was ConocoPhillips, an estimated $3.98M trimmed.
- Y-Intercept (HK)'s largest Q2 2023 buy was Union Pacific: 29,892 shares worth $6.12M.
- Y-Intercept (HK) added most to Blackstone in Q2 2023, an estimated $4.36M increase.
- Y-Intercept (HK)'s biggest Q2 2023 reduction was ConocoPhillips, cutting an estimated $3.98M.
- Y-Intercept (HK) fully exited Cigna in Q2 2023, selling an estimated $7.75M.
- Y-Intercept (HK)'s ten largest holdings make up 5.7% of its $946M portfolio in Q2 2023.
- Y-Intercept (HK) opened 717 new positions and closed 635 in Q2 2023.
- Y-Intercept (HK)'s portfolio value rose 9.8% quarter-over-quarter to $946M.
Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.